Affiliation:
1. The National Research Center for Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya
Abstract
Relevance. Nonspecific anti-epidemic measures against СOVID-19 (mask-wearing, social distancing, lockdowns, homework, quarantines, school closures, tourism bans, etc.) resulted in a significant decrease in the incidence of many respiratory infections. Scientific publications have reported a decrease in the incidence of bacterial purulent meningitis (BMP) during the development of the COVID-19 pandemic.Aims. To review the scientific publications on the decline in the incidence of BMP during the СOVID-19 pandemic.Conclusions.Undoubtedly non-specific anti-epidemic measures taken during the COVID-19 pandemic helped to reduce the incidence of respiratory infections regardless of their etiology and could serve as an indirect indicator of the activity of these measures.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Epidemiology
Reference21 articles.
1. Brueggemann A.B., van Rensberg M.J.J., Shaw D., et al. Changes of the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive Respiratory Surveillance Initiatives: a prospective analysis of surveillance data. Lancet Digit Health, 2021 3:e360–370.
2. Kadambari S., Goldacre R., Morris E., et al. Indirect effectiveness of the covid-19 pandemic on childhood infection in England: population based observation study. BMJ. 2022;376: e067519.
3. Anderson M.R., Arkwright P.D., Bai X., et al. Surveillance and control of meningococcal disease in the COVID-19 era: a Global Meningococcal Initiative review. J. Infection, 2022,84:289–296.
4. Subbarao S., Campbell H., Ribeiro S. et al. Invasive meningococcal disease, 2011-2020, and impact of COVID-19 pandemic, England. Emerg. Infect. Dis., 2021;27( 9):2495–2497.
5. Ladhani S.N., Andrew S. N., Rarikh S.R., et al. Vaccination of infants with meningococcal group B vaccine (4CMenB) in England. N.Engl. Med. J. 2020;382:309–317.